Laparoscopic Sleeve Gastrectomy for Mildly Obese Patients (Body Mass Index of 30 <35 kg/m2): Operative Outcome and Short-Term Results

Background. Data concerning laparoscopic sleeve gastrectomy (LSG) in mild obesity are under investigation.Aim/Objective. May 2010 to May 2012, 122 consecutive patients with preoperative body mass index (BMI) of33±2.5 kg/m2(range 30–34.9) undergoing LSG were studied. Mean age was33±10years (range 15–60), and 105 (86%) were women. Mean preoperative weight was91±9.7 kg (range 66–121), and preoperative excess weight was30±6.7 kg (range 19–43). Comorbidities were detected in 44 (36%) patients.Results. Mean operative time was58±15 min (range 40–95), and postoperative stay was1.8±0.19days (range 1.5–3). There were no admissions to intensive care unit and no deaths within 30 days of surgery. The rates of leaks and strictures were 0%, and of hemorrhage 1.6%. At 12 months, BMI decreased to24.7±2, and the percentage of excess weight loss (% EWL) reached 76.5%. None of the patients had a BMI below 20 kg/m2. Comorbidities resolved in 70.5% or improved in 29.5%. Patient satisfaction scoring (1–5) at least 1 year after was4.6±0.8for body image and4.4±0.6for food tolerance.Conclusion. LSG for mildly obese patients has proved to be technically relatively easy, safe, and benefic in the short term.

Download Full-text

Effect of laparoscopic sleeve gastrectomy on body mass index and metabolic parameters in morbid obese patients

Journal of Obesity and Metabolic Research ◽

10.4103/2347-9906.148598 ◽

2015 ◽

Vol 2 (1) ◽

pp. 5

Author(s):

PrabhdeepSingh Nain ◽

Parminder Singh ◽

Ashish Ahuja ◽

Dipesh Batra ◽

Vikas Garg

Keyword(s):

Body Mass Index ◽

Sleeve Gastrectomy ◽

Laparoscopic Sleeve Gastrectomy ◽

Body Mass ◽

Metabolic Parameters ◽

Obese Patients ◽

Morbid Obese

Download Full-text

Serum myonectin is increased after laparoscopic sleeve gastrectomy

Annals of Clinical Biochemistry International Journal of Laboratory Medicine ◽

10.1177/0004563220942263 ◽

2020 ◽

Vol 57 (5) ◽

pp. 360-364

Author(s):

Lei Li ◽

Qianqian Wang ◽

Chengkun Qin

Keyword(s):

Body Mass Index ◽

Regression Analysis ◽

Sleeve Gastrectomy ◽

Linear Regression ◽

Laparoscopic Sleeve Gastrectomy ◽

Body Mass ◽

Linear Regression Analysis ◽

Acid Uptake ◽

Model Assessment ◽

Obese Patients

Objective Myonectin, a newly discovered myokine, enhances fatty acid uptake in cultured adipocytes and hepatocytes and suppresses circulating levels of free fatty acids in mice. Recent studies showed that serum myonectin concentration is negatively correlated with obesity. This study was undertaken to evaluate the change of serum myonectin in obese patients after laparoscopic sleeve gastrectomy. Methods This study was performed in a population of 42 obese and 58 control subjects from April of 2018 to December of 2019. All obese subjects underwent laparoscopic sleeve gastrectomy. Anthropometric measurements, lipid profiles, HbA1c and serum myonectin were assessed at baseline and six months after laparoscopic sleeve gastrectomy. Results Serum myonectin concentrations were significantly lower in the obese patients than in the controls. Serum myonectin concentrations were increased at six months after laparoscopic sleeve gastrectomy. Simple linear regression analysis indicated that serum myonectin was negatively correlated with weight, waist circumference, hip circumference, body mass index, fasting plasma glucose, homeostasis model assessment of insulin resistance and HbA1c. Only body mass index was still inversely correlated with serum myonectin after multiple linear regression analysis. Conclusion Serum myonectin is correlated with obesity and increased after laparoscopic sleeve gastrectomy.

Download Full-text